Skip to content

Live Events

Live Events

Live Events

Live Events

MEC Basic Full List View

By pinki@katapult.biz / February 16, 2025

MEC Basic

Events

Speciality

Type of Media

Author / Speaker

Title

Search Entries:

«
1
…
43
44
45
46
47
…
66
»

Anticoagulation in the Oncology Patient

Anticoagulation in the Oncology Patient

Pamela Dudkiewicz, ARPN

CLL: Novel Therapies

CLL: Novel Therapies

Javier Pinilla-Ibarz, MD

Myeloma, So Many Therapeutic Options in the Relapse Setting: How to Sequence Them?

Myeloma, So Many Therapeutic Options in the Relapse Setting: How to Sequence Them?

Jonathan Kaufman, MD

Myelodysplasia: Biomarkers, Risk Assessment and Novel Treatments

Myelodysplasia: Biomarkers, Risk Assessment and Novel Treatments

Rami Komrokji, MD

Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges

Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges

Mohamed Kharfan-Dabaja, MD

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

Hugo Fernandez, MD

New Agents and New Toxicities in Malignant Hematology: BCL2 Inhibitors, Anti-BCMA, and FLT3 Inhibitors

New Agents and New Toxicities in Malignant Hematology: BCL2 Inhibitors, Anti-BCMA, and FLT3 Inhibitors

Nicole Ianniello, PharmD

RET, MET & B-RAF mutations in NSCLC

RET, MET & B-RAF mutations in NSCLC

Janakiraman Subramanian, MD, MPH

ERBB2 and NGR1 Pathways in NSCLC

ERBB2 and NGR1 Pathways in NSCLC

Estelamari Rodriguez, MD

ALK, ROS1 & NTRK Mutations in NSCLC

ALK, ROS1 & NTRK Mutations in NSCLC

Corey Langer, MD

EGFR and K-RAS Mutations in NSCLC

EGFR and K-RAS Mutations in NSCLC

Edgardo S. Santos Castillero, MD

Lung Cancer Clinical Scenarios: How Liquid Biopsy Technology Is Delivering Personalized Therapy in NSCLC

Lung Cancer Clinical Scenarios: How Liquid Biopsy Technology Is Delivering Personalized Therapy in NSCLC

Christian Rolfo, MD

Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC

Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC

David Gandara, MD

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Paul Bunn, MD

Integrative Oncology in Cancer Care

Integrative Oncology in Cancer Care

Ashwin Mehta, MD

Thyroid Cancer & Thymic Carcinoma: Recent Advances

Thyroid Cancer & Thymic Carcinoma: Recent Advances

Raja Mudad, MD

Metastatic Cancer Survivorship Care

Metastatic Cancer Survivorship Care

Adrienne M. Vazquez Guerra, MSN, ACNP-BC, AOCN

Neuroendocrine Tumors (NET): Novel Advances in Therapy

Neuroendocrine Tumors (NET): Novel Advances in Therapy

Pasquale W. Benedetto, MD

Castration Resistant Prostate Cancer (CRPC), Non-Metastatic & Metastatic: Novel Therapeutic Advances

Castration Resistant Prostate Cancer (CRPC), Non-Metastatic & Metastatic: Novel Therapeutic Advances

Michael Hurwitz, MD, PhD

Immunotherapy in Metastatic Breast Cancer

Immunotherapy in Metastatic Breast Cancer

Alberto Montero, MD

PI3K and CDK4/6 Strategies: Efficacy Data and Management of Toxicity

PI3K and CDK4/6 Strategies: Efficacy Data and Management of Toxicity

Mohammad Jahanzeb, MD

Updates on Adjuvant, Neoadjuvant & Metastatic Settings in HER2+ Breast Cancer

Updates on Adjuvant, Neoadjuvant & Metastatic Settings in HER2+ Breast Cancer

Hope Rugo, MD

Endocrine Therapy in Non-Metastatic Breast Cancer Setting

Endocrine Therapy in Non-Metastatic Breast Cancer Setting

William J. Gradishar, MD

Bench Lab Advances for Breast Cancer

Bench Lab Advances for Breast Cancer

Mark Pegram, MD

Management of Non-Melanoma Skin Cancers (BCC, SCC & Merkel’s)

Management of Non-Melanoma Skin Cancers (BCC, SCC & Merkel’s)

Belisario Arango, MD

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Alexander Olawaiye, MD

Immunotherapy and Targeted Therapy in Melanoma

Immunotherapy and Targeted Therapy in Melanoma

Sanjiv Agarwala, MD

Toxicities in Immunotherapy

Toxicities in Immunotherapy

Lisa Kottschade, APRN

Immunotherapy in Kidney & Bladder Cancers

Immunotherapy in Kidney & Bladder Cancers

David I. Quinn, MD

Immunotherapy in Lung Cancer

Immunotherapy in Lung Cancer

Luis E. Raez, MD

Displaying 1,321 - 1,350 of 1,953

«
1
…
43
44
45
46
47
…
66
»

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok